Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 5, 2010, Pages 841-850

  Zhang, Xiaowei ^a   Wang, Xiaohong ^a   Zhu, Hongyan ^a   Zhu, Cheng ^b   Wang, Yigang ^a   Pu, William T ^c   Jegga, Anil G ^b   Fan, Guo Chang ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Apoptosis; Cardiomyocyte; COX 2; MicroRNA; Oxidative stress

Indexed keywords

CUG TRIPLET REPEAT BINDING PROTEIN 2; CYCLOOXYGENASE 2; LUCIFERASE; MICRORNA; MICRORNA 144; MICRORNA 451; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR GATA 4; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; RAT; RNA TRANSLATION; UPREGULATION; WESTERN BLOTTING;

AGING; ANIMALS; BASE SEQUENCE; CELL DEATH; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; GATA4 TRANSCRIPTION FACTOR; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICRORNAS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; MYOCYTES, CARDIAC; RATS; REPERFUSION INJURY; RNA-BINDING PROTEINS; UP-REGULATION;

MAMMALIA;

EID: 77957225240     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.08.007     Document Type: Article

References (39)

1. Elsässer A., Suzuki K., Schaper J. Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure. J Mol Cell Cardiol 2000, 32:711-724.
2. Regula K.M., Kirshenbaum L.A. Apoptosis of ventricular myocytes: a means to an end. J Mol Cell Cardiol 2005, 38:3-13.
3. Baek D., Villén J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P. The impact of microRNAs on protein output. Nature 2008, 455:64-71.
4. Selbach M., Schwanhäusser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
5. Cheng Y., Liu X., Zhang S., Lin Y., Yang J., Zhang C. MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol 2009, 47:5-14.
6. Sayed D., He M., Hong C., Gao S., Rane S., Yang Z., et al. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem 2010, 285:20281-20290.
7. Jazbutyte V., Thum T. MicroRNA-21: from cancer to cardiovascular disease. Curr Drug Targets 2010, 11:926-935.
8. Fleissner F., Jazbutyte V., Fiedler J., Gupta S.K., Yin X., Xu Q., et al. Asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a MicroRNA-21-dependent mechanism. Circ Res 2010, 107:138-143.
9. Dore L.C., Amigo J.D., Dos Santos C.O., Zhang Z., Gai X., Tobias J.W., et al. A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc Natl Acad Sci USA 2008, 105:3333-3338.
10. Cheloufi S., Dos Santos C.O., Chong M.M., Hannon G.J. A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature 2010, 465:584-589.
11. Cifuentes D., Xue H., Taylor D.W., Patnode H., Mishima Y., Cheloufi S., et al. A novel miRNA processing pathway independent of dicer requires argonaute2 catalytic activity. Science 2010, 328:1694-1698.
12. Pase L., Layton J.E., Kloosterman W.P., Carradice D., Waterhouse P.M., Lieschke G.J. MiR-451 regulates zebrafish erythroid maturation in vivo via its target gata2. Blood 2009, 113:1794-1804.
13. Dos Santos C.O., Yu D., Amigo J., Kandros E., Valentine E.R., Shelat S., et al. The microRNA144/451 locus enhances nuclear FOXO3a activity to protect erythroid cells against oxidant stress. Blood 2008, 112. (Abstract).
14. Ovcharenko D., Kelnar K., Johnson C., Leng N., Brown D. Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Res 2007, 67:10782-10788.
15. Bandres E., Bitarte N., Arias F., Agorreta J., Fortes P., Agirre X., et al. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 2009, 15:2281-2290.
16. Godlewski J., Nowicki M.O., Bronisz A., Nuovo G., Palatini J., De Lay M., et al. MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell 2010, 37:620-632.
17. Papapetrou E.P., Korkola J.E., Sadelain M. A genetic strategy for single and combinatorial analysis of miRNA function in mammalian hematopoietic stem cells. Stem Cells 2010, 28:287-296.
18. Ren X.P., Wu J., Wang X., Sartor M.A., Qian J., Jones K., et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 2009, 119:2357-2366.
19. Thum T., Galuppo P., Wolf C., Fiedler J., Kneitz S., van Laake L.W., et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007, 116:258-267.
20. Bostjancic E., Zidar N., Glavac D. MicroRNA microarray expression profiling in human myocardial infarction. Dis Markers 2009, 27:255-268.
21. Fan G.C., Chu G., Mitton B., Song Q., Yuan Q., Kranias E.G. Small heat-shock protein Hsp20 phosphorylation inhibits beta-agonist-induced cardiac apoptosis. Circ Res 2004, 94:1474-1482.
22. Kobayashi S., Lackey T., Huang Y., Bisping E., Pu W.T., Boxer L.M., et al. Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo. FASEB J 2006, 20:800-802.
23. Wang X., Zingarelli B., O'Connor M., Zhang P., Adeyemo A., Kranias E.G., et al. Overexpression of Hsp20 prevents endotoxin-induced myocardial dysfunction and apoptosis via inhibition of NF-kappaB activation. J Mol Cell Cardiol 2009, 47:382-390.
24. Islamovic E., Duncan A., Bers D.M., Gerthoffer W.T., Mestril R. Importance of small heat shock protein 20 (hsp20) C-terminal extension in cardioprotection. J Mol Cell Cardiol 2007, 42:862-869.
25. Charron F., Nemer M. GATA transcription factors and cardiac development. Semin Cell Dev Biol 1999, 10:85-91.
26. Liang Q., Molkentin J.D. Divergent signaling pathways converge on GATA4 to regulate cardiac hypertrophic gene expression. J Mol Cell Cardiol 2002, 34:611-616.
27. Suzuki Y.J., Evans T. Regulation of cardiac myocyte apoptosis by the GATA-4 transcription factor. Life Sci 2004, 74:1829-1838.
28. Suzuki Y.J., Nagase H., Day R.M., Das D.K. GATA-4 regulation of myocardial survival in the preconditioned heart. J Mol Cell Cardiol 2004, 37:1195-1203.
29. Mukhopadhyay D., Houchen C.W., Kennedy S., Dieckgraefe B.K., Anant S. Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol Cell 2003, 11:113-126.
30. Sureban S.M., Murmu N., Rodriguez P., May R., Maheshwari R., Dieckgraefe B.K., et al. Functional antagonism between RNA binding proteins HuR and CUGBP2 determines the fate of COX-2 mRNA translation. Gastroenterology 2007, 132:1055-1065.
31. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009, 10:126-139.
32. Xu C., Lu Y., Pan Z., Chu W., Luo X., Lin H., et al. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 2007, 120:3045-3052.
33. Bolli R., Shinmura K., Tang X.L., Kodani E., Xuan Y.T., Guo Y., et al. Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. Cardiovasc Res 2002, 55:506-519.
34. Papanicolaou K.N., Streicher J.M., Ishikawa T.O., Herschman H., Wang Y., Walsh K. Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2. J Mol Cell Cardiol 2010, 49:196-209.
35. Streicher J.M., Kamei K., Ishikawa T.O., Herschman H., Wang Y. Compensatory hypertrophy induced by ventricular cardiomyocyte-specific COX-2 expression in mice. J Mol Cell Cardiol 2010, 49:88-94.
36. Penna C., Mancardi D., Tullio F., Pagliaro P. Postconditioning and intermittent bradykinin induced cardioprotection require cyclooxygenase activation and prostacyclin release during reperfusion. Basic Res Cardiol 2008, 103:368-377.
37. Gres P., Schulz R., Jansen J., Umschlag C., Heusch G. Involvement of endogenous prostaglandins in ischemic preconditioning in pigs. Cardiovasc Res 2002, 55:626-632.
38. Inserte J., Molla B., Aguilar R., Través P.G., Barba I., Martín-Sanz P., et al. Constitutive COX-2 activity in cardiomyocytes confers permanent cardioprotection Constitutive COX-2 expression and cardioprotection. J Mol Cell Cardiol 2009, 46:160-168.
39. Camitta M.G., Gabel S.A., Chulada P., Bradbury J.A., Langenbach R., Zeldin D.C., et al. Cyclooxygenase-1 and -2 knockout mice demonstrate increased cardiac ischemia/reperfusion injury but are protected by acute preconditioning. Circulation 2001, 104:2453-2458.